Literature DB >> 28683268

Physico-Pathologic Mechanisms Involved in Neurodegeneration: Misfolded Protein-Plasma Membrane Interactions.

Amulya Nidhi Shrivastava1, Anita Aperia2, Ronald Melki3, Antoine Triller4.   

Abstract

Several neurodegenerative disorders, such as Alzheimer's and Parkinson's disease, are characterized by prominent loss of synapses and neurons associated with the presence of abnormally structured or misfolded protein assemblies. Cell-to-cell transfer of misfolded proteins has been proposed for the intra-cerebral propagation of these diseases. When released, misfolded proteins diffuse in the 3D extracellular space before binding to the plasma membrane of neighboring cells, where they diffuse on a 2D plane. This reduction in diffusion dimension and the cell surface molecular crowding promote deleterious interactions with native membrane proteins, favoring clustering and further aggregation of misfolded protein assemblies. These processes open up new avenues for therapeutics development targeting the initial interactions of deleterious proteins with the plasma membrane or the subsequent pathological signaling.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer; Parkinson; membrane interaction; pathogenic proteins; prion-like propagation; protein diffusion; protein-aggregation

Mesh:

Substances:

Year:  2017        PMID: 28683268     DOI: 10.1016/j.neuron.2017.05.026

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  35 in total

Review 1.  Progress toward Alzheimer's disease treatment: Leveraging the Achilles' heel of Aβ oligomers?

Authors:  Jacques Fantini; Henri Chahinian; Nouara Yahi
Journal:  Protein Sci       Date:  2020-07-13       Impact factor: 6.725

2.  The Amphipathic GM1 Molecule Stabilizes Amyloid Aggregates, Preventing their Cytotoxicity.

Authors:  Monica Bucciantini; Manuela Leri; Massimo Stefani; Ronald Melki; Sandra Zecchi-Orlandini; Daniele Nosi
Journal:  Biophys J       Date:  2020-06-12       Impact factor: 4.033

3.  Disease Mechanisms of Multiple System Atrophy: What a Parallel Between the Form of Pasta and the Alpha-Synuclein Assemblies Involved in MSA and PD Tells Us.

Authors:  Ronald Melki
Journal:  Cerebellum       Date:  2022-06-03       Impact factor: 3.847

4.  CHIP-dependent regulation of the actin cytoskeleton is linked to neuronal cell membrane integrity.

Authors:  Catarina Dias; Erisa Nita; Jakub Faktor; Ailish C Tynan; Lenka Hernychova; Borivoj Vojtesek; Jesper Nylandsted; Ted R Hupp; Tilo Kunath; Kathryn L Ball
Journal:  iScience       Date:  2021-07-17

5.  Novel functional variants at the GWAS-implicated loci might confer risk to major depressive disorder, bipolar affective disorder and schizophrenia.

Authors:  Leonid O Bryzgalov; Elena E Korbolina; Ilja I Brusentsov; Elena Y Leberfarb; Natalia P Bondar; Tatiana I Merkulova
Journal:  BMC Neurosci       Date:  2018-04-19       Impact factor: 3.288

6.  The differential solvent exposure of N-terminal residues provides 'fingerprints' of alpha-synuclein fibrillar polymorphs.

Authors:  Maud Landureau; Virginie Redeker; Tracy Bellande; Stéphanie Eyquem; Ronald Melki
Journal:  J Biol Chem       Date:  2021-04-29       Impact factor: 5.157

7.  Molecular dynamics study of water channels in natural and synthetic amyloid-β fibrils.

Authors:  S R Natesh; A R Hummels; J R Sachleben; T R Sosnick; K F Freed; J F Douglas; S C Meredith; E J Haddadian
Journal:  J Chem Phys       Date:  2021-06-21       Impact factor: 4.304

Review 8.  Innovative treatment targeting gangliosides aimed at blocking the formation of neurotoxic α-synuclein oligomers in Parkinson's disease.

Authors:  Nouara Yahi; Coralie Di Scala; Henri Chahinian; Jacques Fantini
Journal:  Glycoconj J       Date:  2021-07-30       Impact factor: 2.916

9.  Structural and mechanistic insights into amyloid-β and α-synuclein fibril formation and polyphenol inhibitor efficacy in phospholipid bilayers.

Authors:  Henry M Sanders; Blagojce Jovcevski; Michael T Marty; Tara L Pukala
Journal:  FEBS J       Date:  2021-07-26       Impact factor: 5.542

Review 10.  Alpha-synuclein research: defining strategic moves in the battle against Parkinson's disease.

Authors:  Luis M A Oliveira; Thomas Gasser; Robert Edwards; Markus Zweckstetter; Ronald Melki; Leonidas Stefanis; Hilal A Lashuel; David Sulzer; Kostas Vekrellis; Glenda M Halliday; Julianna J Tomlinson; Michael Schlossmacher; Poul Henning Jensen; Julia Schulze-Hentrich; Olaf Riess; Warren D Hirst; Omar El-Agnaf; Brit Mollenhauer; Peter Lansbury; Tiago F Outeiro
Journal:  NPJ Parkinsons Dis       Date:  2021-07-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.